Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,645 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A case of anti-PL-7 antibody-positive anti-synthetase syndrome with dermatomyositis-associated erythema induced sclerodermatous changes.
Fukuzono M, Sasaki K, Ichimura Y, Inoue S, Iwasaki R, Imai H, Saito A, Kubota N, Tanaka R, Nakamura Y, Fujisawa Y, Fujimoto M, Nomura T, Okiyama N. Fukuzono M, et al. Among authors: nomura t. Rheumatology (Oxford). 2021 Oct 2;60(10):e362-e364. doi: 10.1093/rheumatology/keab370. Rheumatology (Oxford). 2021. PMID: 33892494 No abstract available.
Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.
Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, Tanaka R, Kubota N, Matsumoto I, Ishii A, Tamaoka A, Shimbo A, Mori M, Morio T, Kishi T, Miyamae T, Tanboon J, Inoue M, Nishino I, Fujimoto M, Nomura T, Okiyama N. Ichimura Y, et al. Among authors: nomura t. Rheumatology (Oxford). 2022 Mar 2;61(3):1222-1227. doi: 10.1093/rheumatology/keab518. Rheumatology (Oxford). 2022. PMID: 34152410
Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein properties.
Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, Tanaka R, Kubota N, Matsumoto I, Ishii A, Tamaoka A, Shimbo A, Mori M, Morio T, Kishi T, Miyamae T, Tanboon J, Inoue M, Nishino I, Fujimoto M, Nomura T, Okiyama N. Ichimura Y, et al. Among authors: nomura t. J Dermatol. 2022 Apr;49(4):441-447. doi: 10.1111/1346-8138.16295. Epub 2021 Dec 29. J Dermatol. 2022. PMID: 34967032
Loricrin Protects against Chemical Carcinogenesis.
Ogawa T, Ishitsuka Y, Nakamura Y, Watanabe R, Okiyama N, Fujisawa Y, Fujimoto M, Roop DR, Nomura T. Ogawa T, et al. Among authors: nomura t. J Invest Dermatol. 2022 Jul;142(7):2023-2026.e1. doi: 10.1016/j.jid.2021.12.015. Epub 2021 Dec 27. J Invest Dermatol. 2022. PMID: 34968502 Free article. No abstract available.
The Role of PD-L1 on Langerhans Cells in the Regulation of Psoriasis.
Tanaka R, Ichimura Y, Kubota N, Konishi R, Nakamura Y, Mizuno S, Takahashi S, Fujimoto M, Nomura T, Okiyama N. Tanaka R, et al. Among authors: nomura t. J Invest Dermatol. 2022 Dec;142(12):3167-3174.e9. doi: 10.1016/j.jid.2022.06.006. Epub 2022 Jul 6. J Invest Dermatol. 2022. PMID: 35803322 Free article.
3,645 results